Wireless Implants Market
- Reports Overview
- Table Of Content
- Research Methodology
The global wireless implants market size was estimated at USD 6.70 billion in 2023 and is projected to hit around USD 29.51 billion by 2032, registering a CAGR of 17.90% during the forecast period from 2023 to 2032.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Wireless Implants Market
5.1. COVID-19 Landscape: Wireless Implants Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Wireless Implants Market, By Application
8.1. Wireless Implants Market Revenue and Volume, by Application, 2023-2032
8.1.1. Orthopedic Implants
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Cardiovascular Implants
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Neurological Implants
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Other implants
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Wireless Implants Market, By End-User
9.1. Wireless Implants Market Revenue and Volume, by End-User, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Clinics
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Wireless Implants Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)
Chapter 11. Company Profiles
11.1. Medtronic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Boston Scientific Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Cochlear Limited
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zimmer Biomet Holdings, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. St. Jude Medical (now part of Abbott)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dexcom, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Siemens Healthineers
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. LivaNova PLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. NXP Semiconductors
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Research Methodology
Grand View Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restrains, along with their current
and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and
expected capacity additions up to 2030
We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market leading companies
• Raw
material suppliers
• Product distributors
• Buyers
The key objectives of primary research are as follows:
• To validate our data in terms of accuracy and
acceptability
• To gain an insight in to the current market and future
expectations
Data Collection Matrix
|
Perspective |
Primary research |
Secondary research |
|
Supply side |
|
|
|
Demand side |
|
|
Industry Analysis
Matrix
|
Qualitative analysis |
Quantitative analysis |
|
|
Wireless Implants Market (By Application: Orthopedic Implants, Cardiovascular Implants, Neurological Implants, Other implants; By End-User: Hospitals, Ambulatory Surgical Centers, Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
Key Takeaways
- North America contributed more than 41% of revenue share in 2022.
- Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By application, the orthopedic implants segment has held the largest market share of 45% in 2022.
- By application, the cardiovascular implants segment is anticipated to grow at a remarkable CAGR of 18.4% between 2023 and 2032.
- By end-user, the hospitals segment generated over 36% of revenue share in 2022.
- By end-user, the clinics segment is expected to expand at the fastest CAGR over the projected period.
Wireless Implants Market in the U.S. 2023 To 2032
The U.S. wireless implants market size was valued at USD 1.93 billion in 2023 and is expected to reach USD 8.54 billion by 2032, growing at a CAGR of 18% from 2023 to 2032.
North America held the largest revenue share of 41% in 2022. North America dominates the wireless implant market due to advanced healthcare infrastructure, robust research and development activities, and high healthcare expenditure. The region’s early adoption of innovative technologies, coupled with a favorable regulatory environment, propels the market forward. Additionally, a surge in chronic diseases, a tech-savvy population, and strong collaborations between industry players and research institutions contribute to the significant market share. The presence of major wireless implant manufacturers and a supportive reimbursement landscape further solidify North America’s leading position in this dynamic and evolving healthcare sector.
Asia Pacific is estimated to witness the highest growth. Asia-Pacific dominates the wireless implants market due to factors such as a burgeoning aging population, rising prevalence of chronic diseases, and increasing healthcare investments. The region’s robust technological infrastructure and a surge in healthcare awareness contribute to widespread adoption.
Moreover, favorable government initiatives, supportive regulatory frameworks, and collaborations with key industry players further propel the growth of the wireless implants market in Asia Pacific. The region’s dynamic healthcare landscape and growing demand for advanced medical technologies position it as a key player in shaping the trajectory of the market.
Wireless Implants Market Overview
A wireless implant is a compact electronic device designed for insertion into the human body or other living organisms, primarily for medical or research purposes. Unlike conventional implants that rely on wired connections, wireless implants leverage technologies such as radiofrequency or Bluetooth for communication with external devices. These implants serve diverse functions, ranging from monitoring physiological metrics to administering targeted therapies and augmenting sensory capabilities.
The wireless feature of these implants offers notable advantages, including a diminished risk of infection, enhanced mobility, and the ability to remotely manage or observe the implant without requiring physical access. Scientists and healthcare professionals are actively exploring the potential applications of wireless implants in areas such as neurostimulation for chronic condition management, continual health monitoring, and the improvement of interfaces for prosthetic devices. While technology holds significant promise for advancing healthcare and research, its development and deployment are accompanied by ethical considerations, data security, and privacy concerns.
Growth Factors
- Increasing chronic health conditions: The rising prevalence of chronic diseases necessitates advanced monitoring and treatment options, driving the demand for wireless implants.
- Technological advancements: Ongoing innovations in wireless communication and sensor technologies enhance the capabilities and efficiency of implantable devices.
- Aging population: With a growing elderly population globally, there is an expanding market for wireless implants to address age-related health issues and improve quality of life.
- Miniaturization of devices: Advances in miniaturization allow for smaller and less invasive wireless implants, appealing to both patients and healthcare providers.
- Remote patient monitoring: The shift towards remote healthcare management amplifies the need for wireless implants to monitor patients’ health conditions outside traditional medical settings.
- Rising healthcare expenditure: Increased healthcare spending worldwide contributes to the growth of the wireless implants market as patients and healthcare providers seek advanced and efficient solutions.
- Favorable regulatory environment: Supportive regulatory frameworks encourage innovation and expedite the approval process for wireless implantable medical devices.
- Integration with the Internet of Things (IoT): Wireless implants seamlessly integrating with IoT ecosystems enable real-time data exchange and analytics, enhancing overall healthcare outcomes.
- Expanded applications in neurology: Growing applications of wireless implants in neurostimulation therapies for conditions like Parkinson’s and epilepsy drive market expansion.
- Patient preference for non-invasive solutions: The preference for minimally invasive procedures fosters the adoption of wireless implants, avoiding the need for extensive surgeries.
- Increasing awareness and acceptance: Growing awareness among both patients and healthcare professionals about the benefits of wireless implants contributes to market expansion.
- Proliferation of wearable technology: The popularity of wearable devices creates synergies with wireless implants, fostering a connected health ecosystem.
- Rapid data transmission: Advances in wireless communication technologies enable faster and more reliable transmission of critical health data from implants to external devices.
- Cost-efficiency: Improvements in manufacturing processes and materials contribute to cost reduction, making wireless implants more accessible to a broader population.
- Global telehealth adoption: The widespread adoption of telehealth services promotes the use of wireless implants for remote diagnostics and treatment.
- Collaborations and partnerships: Increased collaborations between technology companies, healthcare providers, and research institutions drive collective efforts for the development and adoption of wireless implant technologies.
- Customization and personalization: The ability to tailor wireless implants to individual patient needs enhances their effectiveness and widens their applicability across various medical conditions.
- Advancements in energy harvesting: Innovative energy harvesting technologies reduce the dependence on traditional power sources, extending the lifespan of wireless implants.
- Reduced complications and infections: Wireless implants, with their minimally invasive nature, contribute to a lower risk of complications and infections compared to traditional wired implants.
- Global connectivity: The increasing need for healthcare solutions that transcend geographical boundaries fuels the demand for globally connected wireless implants, ensuring seamless healthcare delivery on a worldwide scale.
Wireless Implants Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 17.90% |
| Market Size in 2023 | USD 6.70 Billion |
| Market Size by 2032 | USD 29.51 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Application and By End-User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Wireless Implants Market Dynamics
Driver
Increasing chronic health conditions and miniaturization of devices
The escalating incidence of chronic health conditions, such as diabetes, cardiovascular diseases, and neurological disorders, acts as a primary catalyst for the burgeoning demand in the wireless implant market.
As chronic diseases require continuous monitoring and precise management, wireless implants offer a transformative solution by providing real-time data on patients’ physiological parameters. This facilitates proactive healthcare interventions, timely adjustments to treatment plans, and improved overall patient outcomes. The increasing prevalence of chronic illnesses, coupled with the aging global population, propels the need for innovative and non-intrusive healthcare solutions, further amplifying the market demand for wireless implants.
Simultaneously, the miniaturization of devices plays a pivotal role in surging demand for wireless implants. Advancements in technology enable the development of smaller, more discreet implants that are less invasive during insertion. This not only enhances patient comfort and acceptance but also broadens the range of medical applications, making wireless implants suitable for diverse conditions.
The trend toward minimally invasive procedures aligns with the preferences of both healthcare providers and patients, fostering a conducive environment for the widespread adoption of wireless implants across various medical domains. The combination of increasing chronic health conditions and miniaturization positions the wireless implants market at the forefront of transformative healthcare solutions.
Restraint
Limited battery life and regulatory hurdles
Limited battery life and regulatory hurdles collectively impede the market demand for the wireless implants industry. The finite lifespan of batteries in these implants poses a practical constraint, as frequent replacements can lead to increased maintenance costs, inconvenience for patients, and potential health risks. The need for reliable, long-lasting power sources is crucial to ensure the sustained functionality of wireless implants and promote user confidence. Simultaneously, regulatory hurdles pose challenges in terms of market entry for new wireless implant devices. Stringent approval processes and compliance standards delay the introduction of innovative technologies to the market, hindering the pace of industry growth.
The protracted regulatory timelines may stifle investment in research and development, limiting the introduction of cutting-edge solutions. Overcoming these restraints requires concerted efforts from industry stakeholders, regulatory bodies, and technology developers to establish robust standards, streamline approval processes, and address the longevity of power sources for wireless implants, fostering a more conducive environment for market expansion.
Opportunity
Integration with Artificial Intelligence (AI) and global telemedicine growth
The integration of wireless implants with Artificial Intelligence (AI) represents a transformative opportunity for the market. AI can analyze vast amounts of data generated by wireless implants in real time, enabling more accurate diagnostics, personalized treatment plans, and proactive healthcare interventions. This synergy enhances the overall capabilities of wireless implants, positioning them as integral components of advanced, AI-driven healthcare ecosystems.
The convergence of AI and wireless implants not only improves patient outcomes but also opens doors for innovative collaborations between implant developers and AI technology providers. Global telemedicine growth is creating significant opportunities for the wireless implants market by aligning with the increasing demand for remote healthcare solutions. Wireless implants play a crucial role in telemedicine by facilitating remote patient monitoring, diagnostics, and treatment.
The seamless integration of wireless implants into telehealth platforms enhances the effectiveness of virtual healthcare, providing healthcare professionals with real-time patient data and enabling timely interventions. This trend capitalizes on the global shift towards telemedicine, presenting a substantial market opportunity for wireless implants as key enablers of remote healthcare services on a global scale.
Application Insights
In 2022, the orthopedic implants segment held the highest market share of 45% on the basis of the application. The orthopedic implants segment in the wireless implants market refers to the use of wireless technology in devices such as smart joint implants and bone health monitoring systems. These implants offer real-time data on movement, stress, and healing processes, aiding in post-surgical recovery and long-term orthopedic care.
Current trends involve the integration of sensors for monitoring joint conditions, promoting personalized rehabilitation programs, and enhancing patient outcomes. The wireless nature of these orthopedic implants streamlines data collection, allowing for more precise diagnostics and tailored interventions in orthopedic healthcare.
The cardiovascular implants segment is anticipated to witness highest growth at a significant CAGR of 18.4% during the projected period. Cardiovascular implants in the Wireless Implant market refer to devices designed for monitoring and managing heart-related conditions. These implants, utilizing wireless technology, enable continuous tracking of vital cardiovascular parameters, enhancing real-time diagnostics and personalized treatment plans.
In recent trends, cardiovascular wireless implants are witnessing advancements in miniaturization, allowing less invasive procedures, and are increasingly integrated into telehealth solutions for remote monitoring. The focus is on developing innovative technologies to address cardiac health, reflecting a growing demand for effective and connected solutions in cardiovascular care.
End-User Insights
According to the end-user, the hospitals segment has held 36% revenue share in 2022. In the wireless implants market, the hospital segment refers to healthcare institutions utilizing implantable devices for patient monitoring, diagnostics, and treatment. A notable trend in this segment involves the integration of wireless implants with hospital information systems, enhancing data accessibility for healthcare professionals.
As hospitals prioritize advanced technologies to improve patient care, wireless implants offer real-time monitoring capabilities, streamline workflows, and contribute to more efficient and personalized healthcare delivery within the hospital setting. The adoption of wireless implants in hospitals reflects a broader trend towards digital transformation in healthcare.
The clinics segment is anticipated to witness the highest growth over the projected period. In the wireless implants market, the clinics segment refers to medical facilities, often smaller than hospitals, offering a range of healthcare services. A notable trend in this segment involves the increasing adoption of wireless implants for in-clinic diagnostics, monitoring, and minor procedures. Clinics leverage wireless implant technologies to enhance patient care, streamline processes, and provide more comprehensive healthcare services. The convenience, reduced invasiveness, and improved data accessibility offered by wireless implants align with the evolving needs of clinics, driving their integration into routine clinical practices.
Recent Developments
- In May 2023, Medtronic made a strategic move by acquiring Ablation Frontiers, a pioneer in minimally invasive ablation technologies designed for treating atrial fibrillation. This acquisition is anticipated to reinforce Medtronic’s standing within the cardiovascular implant market. By integrating Ablation Frontiers’ innovative solutions, Medtronic aims to diversify its product portfolio, offering advanced treatments for a prevalent heart condition.
- In a parallel development in April 2023, Abbott Laboratories expanded its foothold in the healthcare sector by acquiring Verifi Medical. Verifi Medical specializes in developing neuromodulation devices tailored for chronic pain management. Abbott’s acquisition is poised to broaden its range of pain management solutions and fortify its position in the competitive neuromodulation market, demonstrating the company’s commitment to advancing medical technologies for enhanced patient care.
Wireless Implants Market Players
- Medtronic
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Limited
- Zimmer Biomet Holdings, Inc.
- St. Jude Medical (now part of Abbott)
- Dexcom, Inc.
- Siemens Healthineers
- LivaNova PLC
- NXP Semiconductors
- Biotronik SE & Co. KG
- Ekso Bionics Holdings, Inc.
- MicroPort Scientific Corporation
- Nevro Corp.
- Sensirion AG
Segments Covered in the Report
By Application
- Orthopedic Implants
- Cardiovascular Implants
- Neurological Implants
- Other implants
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get A Sample
